Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Change in Acquisitions & Divestments (2023 - 2025)

BioRestorative Therapies (BRTX) has disclosed Change in Acquisitions & Divestments for 3 consecutive years, with $2.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Acquisitions & Divestments fell 60.83% year-over-year to $2.5 million, compared with a TTM value of $13.4 million through Sep 2025, down 34.05%, and an annual FY2024 reading of $21.5 million, up 2.6% over the prior year.
  • Change in Acquisitions & Divestments was $2.5 million for Q3 2025 at BioRestorative Therapies, down from $3.2 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $7.1 million in Q3 2023 and bottomed at $2.5 million in Q3 2025.
  • Average Change in Acquisitions & Divestments over 3 years is $4.7 million, with a median of $4.1 million recorded in 2024.
  • The sharpest move saw Change in Acquisitions & Divestments soared 43.94% in 2024, then tumbled 60.83% in 2025.
  • Year by year, Change in Acquisitions & Divestments stood at $2.9 million in 2023, then surged by 43.94% to $4.1 million in 2024, then crashed by 38.43% to $2.5 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for BRTX at $2.5 million in Q3 2025, $3.2 million in Q2 2025, and $3.5 million in Q1 2025.